Compare Box Inc (BOX) vs Cytokinetics Inc (CYTK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Box Inc vs Cytokinetics Inc — how do they compare? Box Inc trades at $32.48 (market cap $4.55B), while Cytokinetics Inc trades at $76.28 (market cap $10.63B). The key difference: Cytokinetics Inc is far larger — about 2.3× Box Inc's market cap, and Box Inc is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals.
| BOX | CYTK | |
|---|---|---|
Market Cap | $4.55B | $10.63B |
Sector | Technology | Technology |
52-Week High | $33.60 | $87.26 |
52-Week Low | $21.37 | $34.31 |
Enterprise Value | $5.10B | $10.74B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BOX trades at $33.6, up 1.08% today, with a bullish technical signal and strong analyst consensus. Revenue grew to $1.09B in 2025, with net income reaching $244.62M and a high gross margin of 79.56%. Recent news highlights Box's AI-ready content platform adoption, such as the Quintas Energy partnership announced on July 30, 2026.
The outlook is positive with a $37 consensus price target, but risks include a high P/E of 51.3 and competitive pressures. Earnings beat expectations in two of the last three quarters, supporting growth momentum, though valuation remains elevated relative to peers.
CYTK trades at $77.07, down 0.54% on the day, with a bearish technical signal from moving averages. The company reported a Q2 2026 loss of $1.50 per share, beating estimates, but revenue of $68 million in 2026 reflects a net loss margin of -1,321.12%. Recent UK approval for MYQORZO and positive NICE guidance provide commercial momentum, yet high SG&A costs and negative cash flow from operations highlight ongoing financial strain.
The outlook hinges on MYQORZO's commercial execution and label expansion, with a consensus price target of $111.14 implying 44% upside. Risks include sustained cash burn, competitive pressure, and reliance on aficamten's clinical success. Analyst sentiment is overwhelmingly bullish, but profitability remains distant.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →
